This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, X.-Q.
Right arrow Articles by Lalvani, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, X.-Q.
Right arrow Articles by Lalvani, A.

 Previous Article  |  Next Article 

Infection and Immunity, May 2004, p. 2574-2581, Vol. 72, No. 5
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.5.2574-2581.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Evaluation of T-Cell Responses to Novel RD1- and RD2-Encoded Mycobacterium tuberculosis Gene Products for Specific Detection of Human Tuberculosis Infection

Xiao-Qing Liu,1,2 Davinder Dosanjh,1 Hansa Varia,3 Katie Ewer,1 Paul Cockle,4 Geoffrey Pasvol,3 and Ajit Lalvani1*

Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford,1 TB Research Group, Department of Bacterial Diseases, Veterinary Laboratories Agency—Weybridge, New Haw, Addlestone,4 Department of Infection and Tropical Medicine, Imperial College, Northwick Park Hospital, London HA1 3UJ, United Kingdom,3 Department of Infectious Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing 100730, People's Republic of China2

Received 15 August 2003/ Returned for modification 6 November 2003/ Accepted 26 January 2004

The tuberculin skin test for diagnosing Mycobacterium tuberculosis infection suffers from antigenic cross-reactivity of purified protein derivative with BCG, resulting in poor specificity in BCG-vaccinated populations. Comparative genomics has identified several genetic regions in M. tuberculosis and M. bovis that are deleted in M. bovis BCG. Proteins encoded in these regions will form the basis of new specific T-cell-based blood tests that do not cross-react with BCG, but only two, early secretory antigen target 6 and culture filtrate protein 10, have been studied in detail in humans. We investigated four novel gene products, encoded by RD2 (Rv1989c) and RD1 (Rv3873, Rv3878, and Rv3879c), that are absent from most or all of the vaccine strains of BCG, respectively. Sixty-seven overlapping peptides were tested in ex vivo gamma interferon enzyme-linked immunospot assays in 49 patients with culture-confirmed tuberculosis and 38 healthy BCG-vaccinated donors. Forty-five percent (95% confidence interval [CI], 31 to 57%) and 53% (95% CI, 39 to 67%) of the tuberculosis patients responded to Rv3879c and Rv3873, respectively, identifying these proteins as major M. tuberculosis T-cell antigens in humans, while 35 and 25% of the patients responded to Rv3878 and Rv1989c, respectively. Of the 38 BCG-vaccinated donors, 1 (2.6%) responded to peptides from Rv3878 and Rv3879c, 3 (7.9%) responded to Rv3873, and none responded to Rv1989c. Exclusion of cross-reactive peptides encoded in conserved motifs of Rv3873, a PPE family member, increased its specificity to 97.4%. The high specificity of Rv3879c peptides and nonconserved Rv3873 sequences, together with their moderate sensitivity in tuberculosis patients, identifies these peptides as candidates for inclusion in new T-cell-based tests for M. tuberculosis infection.

* Corresponding author. Mailing address: Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Level 7, Oxford OX3 9DU, United Kingdom. Phone and Fax: (44) 1865 221 331. E-mail: ajit.lalvani{at}ndm.ox.ac.uk.

Editor: S. H. E. Kaufmann

Infection and Immunity, May 2004, p. 2574-2581, Vol. 72, No. 5
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.5.2574-2581.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Lalvani, A., Millington, K. A. (2008). T-cell interferon-{gamma} release assays: can we do better?. Eur Respir J 32: 1428-1430 [Full Text]  
  • Mustafa, A. S., Al-Attiyah, R., Hanif, S. N. M., Shaban, F. A. (2008). Efficient Testing of Large Pools of Mycobacterium tuberculosis RD1 Peptides and Identification of Major Antigens and Immunodominant Peptides Recognized by Human Th1 Cells. CVI 15: 916-924 [Abstract] [Full Text]  
  • Dosanjh, D. P.S., Hinks, T. S.C., Innes, J. A., Deeks, J. J., Pasvol, G., Hackforth, S., Varia, H., Millington, K. A., Gunatheesan, R., Guyot-Revol, V., Lalvani, A. (2008). Improved Diagnostic Evaluation of Suspected Tuberculosis. ANN INTERN MED 148: 325-336 [Abstract] [Full Text]  
  • Lalvani, A. (2007). Diagnosing Tuberculosis Infection in the 21st Century: New Tools To Tackle an Old Enemy. Chest 131: 1898-1906 [Abstract] [Full Text]  
  • Cockle, P. J., Gordon, S. V., Hewinson, R. G., Vordermeier, H. M. (2006). Field Evaluation of a Novel Differential Diagnostic Reagent for Detection of Mycobacterium bovis in Cattle. CVI 13: 1119-1124 [Abstract] [Full Text]  
  • Richeldi, L. (2006). An Update on the Diagnosis of Tuberculosis Infection. Am. J. Respir. Crit. Care Med. 174: 736-742 [Abstract] [Full Text]  
  • Guyot-Revol, V., Innes, J. A., Hackforth, S., Hinks, T., Lalvani, A. (2006). Regulatory T Cells Are Expanded in Blood and Disease Sites in Patients with Tuberculosis. Am. J. Respir. Crit. Care Med. 173: 803-810 [Abstract] [Full Text]  
  • Leyten, E. M. S., Mulder, B., Prins, C., Weldingh, K., Andersen, P., Ottenhoff, T. H. M., van Dissel, J. T., Arend, S. M. (2006). Use of Enzyme-Linked Immunospot Assay with Mycobacterium tuberculosis- Specific Peptides for Diagnosis of Recent Infection with M. tuberculosis after Accidental Laboratory Exposure.. J. Clin. Microbiol. 44: 1197-1201 [Abstract] [Full Text]  
  • Ewer, K., Cockle, P., Gordon, S., Mansoor, H., Govaerts, M., Walravens, K., Marche, S., Hewinson, G., Vordermeier, M. (2006). Antigen Mining with Iterative Genome Screens Identifies Novel Diagnostics for the Mycobacterium tuberculosis Complex. CVI 13: 90-97 [Abstract] [Full Text]  
  • Spencer, J. S., Dockrell, H. M., Kim, H. J., Marques, M. A. M., Williams, D. L., Martins, M. V. S. B., Martins, M. L. F., Lima, M. C. B. S., Sarno, E. N., Pereira, G. M. B., Matos, H., Fonseca, L. S., Sampaio, E. P., Ottenhoff, T. H. M., Geluk, A., Cho, S.-N., Stoker, N. G., Cole, S. T., Brennan, P. J., Pessolani, M. C. V. (2005). Identification of Specific Proteins and Peptides in Mycobacterium leprae Suitable for the Selective Diagnosis of Leprosy. J. Immunol. 175: 7930-7938 [Abstract] [Full Text]  
  • Geluk, A., Klein, M. R., Franken, K. L. M. C., van Meijgaarden, K. E., Wieles, B., Pereira, K. C., Buhrer-Sekula, S., Klatser, P. R., Brennan, P. J., Spencer, J. S., Williams, D. L., Pessolani, M. C. V., Sampaio, E. P., Ottenhoff, T. H. M. (2005). Postgenomic Approach To Identify Novel Mycobacterium leprae Antigens with Potential To Improve Immunodiagnosis of Infection. Infect. Immun. 73: 5636-5644 [Abstract] [Full Text]  
  • Kang, Y. A., Lee, H. W., Yoon, H. I., Cho, B., Han, S. K., Shim, Y.-S., Yim, J.-J. (2005). Discrepancy Between the Tuberculin Skin Test and the Whole-Blood Interferon {gamma} Assay for the Diagnosis of Latent Tuberculosis Infection in an Intermediate Tuberculosis-Burden Country. JAMA 293: 2756-2761 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»